Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8350079 Treprostinil formulation

Patent 8350079 was granted and assigned to United Therapeutics on January, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Oct, 2024

"update inverses"

Golden AI

edited on 2 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12102610 Treprostinil salt

Edits on 29 Nov, 2023

"Add patent abstract"

Golden AI

edited on 29 Nov, 2023

Edits made to:

Article (+163 characters)

Article

Patent abstract

There is provided a stable monohydrate form of treprostinil and pharmaceutical formulation comprising the same, method of making and using the same.

Edits on 21 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 21 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Inventor Names

David A. Walsh0

Edits on 20 Sep, 2023

"update inverses"

Golden AI

edited on 20 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11759425 Dry powder compositions of treprostinil prodrugs and methods of use thereof

Edits on 7 Sep, 2023

"update inverses"

Golden AI

edited on 7 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11744836 Dry powder treprostinil for the treatment of pulmonary hypertension

"update inverses"

Golden AI

edited on 7 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11744835 Dry powder treprostinil for the treatment of pulmonary hypertension

Edits on 2 Aug, 2023

"update inverses"

Golden AI

edited on 2 Aug, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11712442 Dry powder treprostinil for the treatment of pulmonary hypertension

Edits on 14 Jun, 2023

"update inverses"

Golden AI

edited on 14 Jun, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11672775 Treprostinil prodrugs

Edits on 31 May, 2023

"update inverses"

Golden AI

edited on 31 May, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11660304 Dry powder treprostinil for the treatment of pulmonary hypertension

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08350079 Treprostinil formulation US Patent 8350079 Treprostinil formulation

Infobox

Patent Number

083500790

Patent Number

83500790

Edits on 23 Sep, 2022

"Entity importer update"

Golden AI

edited on 23 Sep, 2022

Infobox

Is a

Patent

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

083500790

Date of Patent

January 8, 2013

Patent Application Number

124370540

Date Filed

May 7, 2009

Patent Primary Examiner

‌

Yevegeny Valenrod

Edits on 15 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 15 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08350079 Treprostinil formulation

Infobox

Is a

Patent

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08350079

Date of patent

January 8, 2013

Patent application number

12437054

Date Filed

May 7, 2009

Patent primary examiner

‌

Yevegeny Valenrod

Find more entities like US Patent 8350079 Treprostinil formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.